Shebl A - Search Results

1

Restabilization treatment after intravenous immunoglobulin withdrawal in chronic inflammatory demyelinating polyneuropathy: Results from the pre-randomization phase of the Polyneuropathy And Treatment with Hizentra study.

Mielke O, Bril V, Cornblath DR, Lawo JP, van Geloven N, Hartung HP, Lewis RA, Merkies ISJ, Sobue G, Durn B, Shebl A, van Schaik IN; PATH study group. Mielke O, et al. Among authors: shebl a. J Peripher Nerv Syst. 2019 Mar;24(1):72-79. doi: 10.1111/jns.12303. Epub 2019 Mar 1. J Peripher Nerv Syst. 2019. PMID: 30672067 Free PMC article.

2

Efficacy and safety of Privigen(®) in patients with chronic inflammatory demyelinating polyneuropathy: results of a prospective, single-arm, open-label Phase III study (the PRIMA study).

Léger JM, De Bleecker JL, Sommer C, Robberecht W, Saarela M, Kamienowski J, Stelmasiak Z, Mielke O, Tackenberg B, Shebl A, Bauhofer A, Zenker O, Merkies IS; PRIMA study investigators. Léger JM, et al. Among authors: shebl a. J Peripher Nerv Syst. 2013 Jun;18(2):130-40. doi: 10.1111/jns5.12017. J Peripher Nerv Syst. 2013. PMID: 23781960 Free PMC article. Clinical Trial.

3

Isoagglutinin reduction in intravenous immunoglobulin (IgPro10, Privigen) by specific immunoaffinity chromatography reduces its reporting rates of hemolytic reactions: an analysis of spontaneous adverse event reports.

Shebl A, Gabriel S, Van Dinther K, Hubsch A, Lawo JP, Hoefferer L, Welsh S. Shebl A, et al. Transfusion. 2020 Jun;60(6):1278-1286. doi: 10.1111/trf.15846. Epub 2020 May 14. Transfusion. 2020. PMID: 32410287 Free PMC article.

4

Mielke O, Fontana S, Goranova-Marinova V, Shebl A, Spycher MO, Wymann S, Durn BL, Lawo JP, Hubsch A, Salama A. Mielke O, et al. Among authors: shebl a. Transfusion. 2017 Nov;57(11):2629-2638. doi: 10.1111/trf.14289. Epub 2017 Aug 25. Transfusion. 2017. PMID: 28840942 Clinical Trial.

5

Incidence and risk factors for intravenous immunoglobulin-related hemolysis: A systematic review of clinical trial and real-world populations.

Cuesta H, El Menyawi I, Hubsch A, Hoefferer L, Mielke O, Gabriel S, Shebl A. Cuesta H, et al. Among authors: shebl a. Transfusion. 2022 Sep;62(9):1894-1907. doi: 10.1111/trf.17028. Epub 2022 Aug 2. Transfusion. 2022. PMID: 35916266 Free PMC article. Review.

6

Anti-A/B isoagglutinin reduction in an intravenous immunoglobulin product and risk of hemolytic anemia: a hospital-based cohort study.

Wallenhorst C, Patel A, Shebl A, Hubsch A, Simon TL, Martinez C. Wallenhorst C, et al. Among authors: shebl a. Transfusion. 2020 Jul;60(7):1381-1390. doi: 10.1111/trf.15859. Epub 2020 Jun 2. Transfusion. 2020. PMID: 32488887 Free PMC article.

7

Impact of screening and exclusion of high anti-A titer donors on the risk of hemolytic anemia with intravenous immunoglobulin treatment: A hospital-based cohort study in the US.

Martinez C, Watson DJ, Shebl A, Wallenhorst C, Hubsch A, Simon TL. Martinez C, et al. Among authors: shebl a. Am J Hematol. 2018 Jan;93(1):E17-E20. doi: 10.1002/ajh.24931. Epub 2017 Oct 31. Am J Hematol. 2018. PMID: 28983941 Free PMC article. No abstract available.

8

Hemolytic events associated with intravenous immune globulin therapy: a qualitative analysis of 263 cases reported to four manufacturers between 2003 and 2012.

Berg R, Shebl A, Kimber MC, Abraham M, Schreiber GB. Berg R, et al. Among authors: shebl a. Transfusion. 2015 Jul;55 Suppl 2:S36-46. doi: 10.1111/trf.13198. Transfusion. 2015. PMID: 26174896

9

Safety and tolerability of IgPro10 in Japanese primary immunodeficiency patients: a registrational study.

Morio T, Gotoh K, Imagawa T, Morita K, Ohnishi H, Yasui K, Hofmann J, Lawo JP, Shebl A, Rojavin MA. Morio T, et al. Among authors: shebl a. Int J Hematol. 2021 Jun;113(6):921-929. doi: 10.1007/s12185-021-03106-w. Epub 2021 Mar 18. Int J Hematol. 2021. PMID: 33738703 Clinical Trial.

10

Safety of biweekly α₁-antitrypsin treatment in the RAPID programme.

Greulich T, Chlumsky J, Wencker M, Vit O, Fries M, Chung T, Shebl A, Vogelmeier C, Chapman KR, McElvaney NG; RAPID Trial Group. Greulich T, et al. Among authors: shebl a. Eur Respir J. 2018 Nov 29;52(5):1800897. doi: 10.1183/13993003.00897-2018. Print 2018 Nov. Eur Respir J. 2018. PMID: 30237305 Free PMC article. Clinical Trial.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

56 results

Search Page

Filters